secwatch.observer — SEC 8-K summary
======================================

Issuer:     Emmaus Life Sciences, Inc. (EMMA)
CIK:        0000822370
Form:       8-K
Filed at:   2022-10-06T23:59:59+00:00
Accession:  0001213900-22-062300
Event type: leadership
Sentiment:  neutral
Materiality: 0.55
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Emmaus Life Sciences appoints Ian Zwicker and Dr. Seah Lim to Board; Lim loans $1.2M
--------------------------------------------------------------------------------

- Ian Zwicker appointed to Board and as Chair of Audit Committee; will receive $25,000 for audit committee service.
- Dr. Seah Lim appointed to fill Board vacancy; brings expertise in hematology, oncology, and sickle cell disease.
- Dr. Lim loaned Emmaus $1.2M at 6% interest, due in 3 years, with one restricted share per $5 principal.
- Loan proceeds used to augment working capital and for general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/0001213900-22-062300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/822370/000121390022062300/ea166525-8k_emmauslife.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-062300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer